Medication Interactions: Certain medications can affect your bodys response to exercise, potentially causing adverse reactions or reducing the efficacy of the medication itself
Wenjing, H
Patients with type 1 diabetes, kidney cancer, or kidney failure (eGFR 30 mg/g) [19]
2040 EORTC item Q168: the psychometric performance of a single-item indicator of side-effect burden for people with cancer Tamara Jones 1 , Florian Zeman 2 , Michael Koller 2 , Andreia Moura 3 , Claire Piccinin 3 , Sandra Nolte 1 1 Person-Centred Research, Eastern Health Clinical School, Monash University, Melbourne, Australia, 2 Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 3 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2040 Aims Following the release of the US Food and Drug Administration (FDA) Guidance on core patient-reported outcomes in cancer clinical trials, there has been growing interest in using single items to measure treatment tolerability from the patients perspective

Other side effects to monitor Patients switching between formulations should also be aware of potential headaches associated with GLP-1 therapy , tirzepatide body aches , muscle pain , insomnia , and semaglutide-related sleep disruption